SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-022788
Filing Date
2022-08-15
Accepted
2022-08-15 08:10:40
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tpst-20220630.htm   iXBRL 10-Q 1412252
2 EX-10.5 agreementforterminationofl.htm EX-10.5 27614
3 EX-31.1 exhibit31121.htm EX-31.1 9652
4 EX-31.2 exhibit31221.htm EX-31.2 9579
5 EX-32.1 exhibit32121.htm EX-32.1 6922
  Complete submission text file 0001628280-22-022788.txt   5492935

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpst-20220630.xsd EX-101.SCH 38061
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpst-20220630_cal.xml EX-101.CAL 50158
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpst-20220630_def.xml EX-101.DEF 165975
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tpst-20220630_lab.xml EX-101.LAB 458930
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpst-20220630_pre.xml EX-101.PRE 305604
58 EXTRACTED XBRL INSTANCE DOCUMENT tpst-20220630_htm.xml XML 737907
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 221162462
SIC: 2834 Pharmaceutical Preparations